ABSTRACT
Hypertension is associated with oxidative stress and perivascular inflammation, critical contributors to perivascular fibrosis and accelerated vascular ageing. Oxidative stress can promote vascular inflammation, creating options for potential use of NADPH oxidase inhibitors in pharmacological targeting of perivascular inflammation and its consequences. Accordingly, we characterized age-related changes in oxidative stress and immune cell infiltration in normotensive (WKY) and spontaneously hypertensive rats (SHRs). Subsequently, we used pharmacological inhibitors of Nox1 (ML171) and Nox1/Nox4 (GKT137831; 60 mg/kg), to modulate NADPH oxidase activity at the early stage of spontaneous hypertension and investigated their effects on perivascular inflammation and fibrosis. RESULTS: Ageing was associated with a progressive increase of blood pressure as well as an elevation of the total number of leukocytes, macrophages and NK cells infiltrating perivascular adipose tissue (PVAT) in SHRs but not in WKY. At 1 month of age, when blood pressure was not yet different, only perivascular NK cells were significantly higher in SHR. Spontaneous hypertension was also accompanied by the higher perivascular T cell accumulation, although this increase was age independent. Aortic Nox1 and Nox2 mRNA expression increased with age only in SHR but not in WKY, while age-related increase of Nox4 mRNA in the vessels has been observed in both groups, it was more pronounced in SHRs. At early stage of hypertension (3-months) the most pronounced differences were observed in Nox1 and Nox4. Surprisingly, GKT137831, dual inhibitor of Nox1/4, therapy increased both blood pressure and perivascular macrophage infiltration. Mechanistically, this was linked to increased expression of proinflammatory chemokines expression (CCL2 and CCL5) in PVAT. This inflammatory response translated to increased perivascular fibrosis. This effect was likely Nox4 dependent as the Nox1 inhibitor ML171 did not affect the development of spontaneous hypertension, perivascular macrophage accumulation, chemokine expression nor adventitial collagen deposition. In summary, spontaneous hypertension promotes ageing-associated perivascular inflammation which is exacerbated by Nox4 but not Nox1 pharmacological inhibition.
Subject(s)
Adipose Tissue/drug effects , Aorta/drug effects , Enzyme Inhibitors/toxicity , Hypertension/complications , NADPH Oxidase 1/antagonists & inhibitors , NADPH Oxidase 4/antagonists & inhibitors , Vasculitis/chemically induced , Adipose Tissue/enzymology , Adipose Tissue/immunology , Adipose Tissue/pathology , Age Factors , Animals , Aorta/enzymology , Aorta/immunology , Aorta/pathology , Blood Pressure , Disease Models, Animal , Fibrosis , Hypertension/physiopathology , Inflammation Mediators/metabolism , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Macrophages/drug effects , Macrophages/immunology , Macrophages/metabolism , Male , NADPH Oxidase 1/metabolism , NADPH Oxidase 4/metabolism , Pyrazolones/toxicity , Pyridones/toxicity , Rats, Inbred SHR , Rats, Inbred WKY , Signal Transduction , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Vasculitis/enzymology , Vasculitis/immunology , Vasculitis/pathologyABSTRACT
Atherosclerosis is a major cardiovascular disease and in 2016, the World Health Organisation (WHO) estimated 17.5 million global deaths, corresponding to 31% of all global deaths, were driven by inflammation and deposition of lipids into the arterial wall. This leads to the development of plaques which narrow the vessel lumen, particularly in the coronary and carotid arteries. Atherosclerotic plaques can become unstable and rupture, leading to myocardial infarction or stroke. Extracellular vesicles (EVs) are a heterogeneous population of vesicles secreted from cells with a wide range of biological functions. EVs participate in cell-cell communication and signalling via transport of cargo including enzymes, DNA, RNA and microRNA in both physiological and patholophysiological settings. EVs are present in atherosclerotic plaques and have been implicated in cellular signalling processes in atherosclerosis development, including immune responses, inflammation, cell proliferation and migration, cell death and vascular remodeling during progression of the disease. In this review, we summarise the current knowledge regarding EV signalling in atherosclerosis progression and the potential of utilising EV signatures as biomarkers of disease.
Subject(s)
Atherosclerosis/metabolism , Cell Communication , Extracellular Vesicles/metabolism , MicroRNAs/metabolism , Biomarkers/metabolism , Cell Proliferation , Humans , Signal Transduction , Vascular RemodelingABSTRACT
Antimicrobial peptides (AMPs) are small cationic molecules that display antimicrobial activity against a wide range of bacteria, fungi and viruses. For an AMP to be considered as a therapeutic option, it must have not only potent antibacterial properties but also low hemolytic and cytotoxic activities [1]. Even though many studies have been conducted in order to correlate the antimicrobial activity with affinity toward model lipid membranes, the use of these membranes to explain cytotoxic effects (especially hemolysis) has been less explored. In this context, we studied lipid selectivity in two related novel AMPs, peptide 6 (P6) and peptide 6.2 (P6.2). Each peptide was designed from a previously reported AMP, and specific amino acid replacements were performed in an attempt to shift their hydrophobic moment or net charge. P6 showed no antimicrobial activity and high hemolytic activity, and P6.2 exhibited good antibacterial and low hemolytic activity. Using both peptides as a model we correlated the affinity toward membranes of different lipid composition and the antimicrobial and hemolytic activities. Our results from surface pressure and zeta potential assays showed that P6.2 exhibited a higher affinity and faster binding kinetic toward PG-containing membranes, while P6 showed this behavior for pure PC membranes. The final position and structure of P6.2 into the membrane showed an alpha-helix conversion, resulting in a parallel alignment with the Trps inserted into the membrane. On the other hand, the inability of P6 to adopt an amphipathic structure, plus its lower affinity toward PG-containing membranes seem to explain its poor antimicrobial activity. Regarding erythrocyte interactions, P6 showed the highest affinity toward erythrocyte membranes, resulting in an increased hemolytic activity. Overall, our data led us to conclude that affinity toward negatively charged lipids instead of zwitterionic ones seems to be a key factor that drives from hemolytic to antimicrobial activity.
Subject(s)
Anti-Bacterial Agents/pharmacology , Antimicrobial Cationic Peptides/pharmacology , Hemolysis/drug effects , Lipids/pharmacology , Pseudomonas aeruginosa/drug effects , Staphylococcus aureus/drug effects , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Antimicrobial Cationic Peptides/chemical synthesis , Antimicrobial Cationic Peptides/chemistry , Dose-Response Relationship, Drug , Erythrocyte Membrane/drug effects , Humans , Lipids/chemistry , Microbial Sensitivity Tests , Structure-Activity RelationshipABSTRACT
We have previously shown that neutrophilic elastase converts human immature dendritic cells (DCs) into TGF-ß secreting cells and reduces its allostimulatory ability. Since TGF-ß has been involved in regulatory T cells (Tregs) induction we analyzed whether elastase or neutrophil-derived culture supernatant treated DCs induce CD4(+)FOXP3(+) Tregs in a mixed lymphocyte reaction (MLR). We found that elastase or neutrophil-derived culture supernatant treated DCs increased TGF-ß and decreased IL-6 production. Together with this pattern of cytokines, we observed a higher number of CD4(+)FOXP3(+) cells in the MLR cultures induced by elastase or neutrophil-derived culture supernatant treated DCs but not with untreated DCs. The higher number of CD4(+)FOXP3(+) T cell population was not observed when the enzymatic activity of elastase was inhibited with an elastase specific inhibitor and also when a TGF-ß1 blocking antibody was added during the MLR culture. The increased number of CD4(+) that express FOXP3 was also seen when CD4(+)CD25(-) purified T cells were cocultured with the TGF-ß producing DCs. Furthermore, these FOXP3(+) T cells showed suppressive activity in vitro. These results identify a novel mechanism by which the tolerogenic DCs generated by elastase exposure contribute to the immune regulation and may be relevant in the pathogenesis of several lung diseases where the inflammatory infiltrate contains high numbers of neutrophils and high elastase concentrations.
Subject(s)
Dendritic Cells/immunology , Forkhead Transcription Factors/metabolism , Leukocyte Elastase/pharmacology , T-Lymphocytes, Regulatory/immunology , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/pharmacology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Culture Media, Conditioned/metabolism , Culture Media, Conditioned/pharmacology , Dendritic Cells/drug effects , Dendritic Cells/metabolism , Humans , Immune Tolerance/immunology , Interleukin-2 Receptor alpha Subunit/metabolism , Interleukin-6/metabolism , Leukocyte Elastase/antagonists & inhibitors , Leukocytes, Mononuclear/immunology , Lymphocyte Culture Test, Mixed , Neutrophils/metabolism , Secretory Leukocyte Peptidase Inhibitor/pharmacology , T-Lymphocytes, Regulatory/metabolism , Transforming Growth Factor beta1/antagonists & inhibitors , Transforming Growth Factor beta1/immunology , Transforming Growth Factor beta1/metabolismABSTRACT
BACKGROUND AND PURPOSE: T-cells may play a role in the evolution of ischaemic damage and repair, but the ability to image these cells in the living brain after a stroke has been limited. We aim to extend the technique of real-time in situ brain imaging of T-cells, previously shown in models of immunological diseases, to models of experimental stroke. EXPERIMENTAL APPROACH: Male C57BL6 mice (6-8 weeks) (n= 3) received a total of 2-5 x 10(6) carboxyfluorescein diacetate succinimidyl ester (CFSE)-labelled lymphocytes from donor C57BL6 mice via i.v. injection by adoptive transfer. Twenty-four hours later, recipient mice underwent permanent left distal middle cerebral artery occlusion (MCAO) by electrocoagulation or by sham surgery under isoflurane anaesthesia. Female hCD2-green fluorescent protein (GFP) transgenic mice that exhibit GFP-labelled T-cells underwent MCAO. At 24 or 48 h post-MCAO, a sagittal brain slice (1500 microm thick) containing cortical branches of the occluded middle cerebral artery (MCA) was dissected and used for multiphoton laser scanning microscopy (MPLSM). KEY RESULTS: Our results provide direct observations for the first time of dynamic T-cell behaviour in living brain tissue in real time and herein proved the feasibility of MPLSM for ex vivo live imaging of immune response after experimental stroke. CONCLUSIONS AND IMPLICATIONS: It is hoped that these advances in the imaging of immune cells will provide information that can be harnessed to a therapeutic advantage.
Subject(s)
Brain/metabolism , Infarction, Middle Cerebral Artery/metabolism , Microscopy, Fluorescence, Multiphoton , Molecular Imaging , Molecular Probe Techniques , T-Lymphocytes/metabolism , Adoptive Transfer , Animals , Brain/immunology , Disease Models, Animal , Feasibility Studies , Female , Fluoresceins/metabolism , Fluorescent Dyes/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Infarction, Middle Cerebral Artery/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Succinimides/metabolism , T-Lymphocytes/immunology , T-Lymphocytes/transplantation , Time FactorsABSTRACT
T-cells are known to play a role in the pathology associated with experimental cerebral malaria, although it has not previously been possible to examine their behaviour in brain. Using multiphoton laser scanning microscopy, we have examined the migration and movement of these cells in brain tissue. We believe that this approach will help define host-parasite interactions and examine how intervening in these relationships affects the development of cerebral pathology.
Subject(s)
Brain/immunology , Brain/pathology , Cell Movement/immunology , Malaria, Cerebral/immunology , Malaria, Cerebral/pathology , Microscopy, Confocal/methods , T-Lymphocytes/immunology , Animals , MiceABSTRACT
In this study we investigated, for the first time in vivo, the effect of cloricromene, a cumarine derivative, on NF-kappaB activation in endotoxin-treated rats. Endotoxemia was induced in male rats by the intravenous injection of Salmonella typhosa lipopolysaccharide (LPS; 2 mg/kg/i.v.). In vivo treatment with cloricromene (2 mg/kg/i.v.) 30 min before lipopolysaccharide administration reversed the LPS-induced loss in tone of the aortic rings, improved their reactivity to phenylephrine, decreased both nitric oxide (NO) and TNF-alpha serum levels by inhibiting LPS-induced inducible NO synthase and TNF-alpha mRNA expression, and interestingly inhibited LPS-induced NF-kappaB activation. Our data suggest that cloricromene protects rats from LPS by blocking LPS-induced NF-kappaB activation, leading to inhibition of NO and TNF-alpha overproduction and thereby reversing the LPS-induced vascular hyporeactivity.
Subject(s)
Chromonar/analogs & derivatives , Chromonar/therapeutic use , Endotoxemia/drug therapy , NF-kappa B/antagonists & inhibitors , Salmonella typhi , Animals , Aorta, Thoracic/drug effects , Aorta, Thoracic/metabolism , Aorta, Thoracic/physiology , Electrophoretic Mobility Shift Assay , Endotoxemia/metabolism , Endotoxemia/physiopathology , In Vitro Techniques , Male , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , NF-kappa B/genetics , NF-kappa B/metabolism , Nitrates/blood , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type II , Nitrites/blood , Phenylephrine , RNA, Messenger/antagonists & inhibitors , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/geneticsABSTRACT
We have studied the effect of propolis and its main active ingredient caffeic acid phenetyl ester (CAPE) on formation of aberrant crypt foci (ACF) and tumors in the rat colon in vivo. CAPE (50 mg/kg i.p.) reduced the formation of ACF and tumor induced by azoxymethane, while propolis ethanolic extract was without effect. These results suggest a potential anti-carcinogenesis of CAPE but not propolis.
Subject(s)
Anticarcinogenic Agents/pharmacology , Caffeic Acids/pharmacology , Colonic Neoplasms/prevention & control , Phenylethyl Alcohol/analogs & derivatives , Phenylethyl Alcohol/pharmacology , Phytotherapy , Propolis/pharmacology , Animals , Anticarcinogenic Agents/administration & dosage , Anticarcinogenic Agents/therapeutic use , Azoxymethane , Caffeic Acids/administration & dosage , Caffeic Acids/therapeutic use , Colon/drug effects , Colon/pathology , Colonic Neoplasms/chemically induced , Colonic Neoplasms/pathology , Male , Phenylethyl Alcohol/administration & dosage , Phenylethyl Alcohol/therapeutic use , Plant Extracts/administration & dosage , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Propolis/administration & dosage , Propolis/therapeutic use , Random Allocation , Rats , Rats, WistarABSTRACT
Two ethanolic propolis extracts (EPE) with and without the caffeic acid phenethyl ester (CAPE), CAPE and galangin (major components of propolis) were investigated for anti-inflammatory activity in rats using carrageenin foot oedema, carrageenin pleurisy and adjuvant arthritis. In our experiments, EPE with CAPE and CAPE alone significantly inhibited carrageenin oedema, carrageenin pleurisy and adjuvant arthritis. In contrast EPE without CAPE and galangin did not exhibit anti-inflammatory effects in acute and chronic inflammation. These results suggest that the anti-inflammatory activity of propolis is due to CAPE.
Subject(s)
Anti-Inflammatory Agents/pharmacology , Arthritis/prevention & control , Edema/prevention & control , Phenylethyl Alcohol/analogs & derivatives , Phytotherapy , Pleurisy/prevention & control , Propolis/pharmacology , Acute Disease , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/therapeutic use , Arthritis/chemically induced , Caffeic Acids/administration & dosage , Caffeic Acids/chemistry , Caffeic Acids/pharmacology , Caffeic Acids/therapeutic use , Carrageenan , Cell Division/drug effects , Chronic Disease , Edema/chemically induced , Flavonoids/administration & dosage , Flavonoids/chemistry , Flavonoids/pharmacology , Flavonoids/therapeutic use , Male , Phenylethyl Alcohol/administration & dosage , Phenylethyl Alcohol/chemistry , Phenylethyl Alcohol/pharmacology , Phenylethyl Alcohol/therapeutic use , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Pleurisy/chemically induced , Propolis/administration & dosage , Propolis/chemistry , Propolis/therapeutic use , Rats , Rats, Inbred Lew , Rats, Wistar , T-Lymphocytes/drug effects , Time FactorsABSTRACT
In the present study we investigated in the reverse passive Arthus reaction elicited in the rat skin the anti-inflammatory effect of double-stranded oligodeoxynucleotides (ODN) with consensus nuclear factor-kappaB (NF-kappaB) sequence as transcription factor decoys (TFD) to inhibit NF-kappaB binding to native DNA sites. Local administration of wild-type-, but not mutant-decoy ODN, dose-dependently reduced both plasma leakage and neutrophil infiltration in rat skin. Molecular analysis performed on soft tissue obtained from rat skin demonstrated: (1) an inhibition of NF-kappaB/DNA binding activity; (2) a decreased nuclear level of p50 and p65 NF-kappaB subunits; (3) an inhibition of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) protein expression, two inflammatory enzymes transcriptionally controlled by NF-kappaB. Furthermore, SN-50, a cell-permeable peptide capable of inhibiting the nuclear translocation of NF-kappaB complexes, as well as ammonium pyrrolidine dithiocarbamate, an inhibitor of NF-kappaB activation, exhibited a similar profile of activity of decoy ODN. Our results indicate that decoy ODN, acting as an in vivo competitor for the transcription factor's ability to bind to cognate recognition sequence, may represent a novel strategy to modulate immune reactions.
Subject(s)
Antioxidants/pharmacology , Arthus Reaction/metabolism , NF-kappa B/metabolism , Skin/drug effects , Thiocarbamates/pharmacology , Transcription Factors/pharmacology , Analysis of Variance , Animals , Cyclooxygenase 2 , DNA/metabolism , Drug Interactions , Isoenzymes/antagonists & inhibitors , Male , Prostaglandin-Endoperoxide Synthases , Pyrrolidines/pharmacology , Rats , Rats, Wistar , Skin/metabolismABSTRACT
In this study, using rat carrageenin-induced pleurisy, we found that treatment of rats with either indomethacin or NS-398 suppressed the pleurisy at 2 h but significantly exacerbated this reaction at 48 h. Exacerbated inflammation was associated with reduced prostaglandin D(2) levels, decreased heat shock factor 1 (HSF1) activation, reduced hsp72 expression and increased activation of nuclear factor kappaB (NF-kappaB). Replacement of cyclopentenone prostaglandins by treating rats with either prostaglandin J(2) or prostaglandin D(2) reversed the exacerbating effects of cyclooxygenase inhibitors leading to the resolution of the reaction. In conclusion, we demonstrate that cyclopentenone prostaglandins may act as anti-inflammatory mediators by inducing in inflammatory cells HSF1-dependent hsp72 expression and NF-kappaB inhibition, two crucial events for the remission of inflammation.
Subject(s)
Heat-Shock Proteins/metabolism , NF-kappa B/metabolism , Pleura/metabolism , Pleurisy/metabolism , Prostaglandin D2/analogs & derivatives , Prostaglandin D2/pharmacology , Prostaglandins/metabolism , Active Transport, Cell Nucleus/drug effects , Animals , Carrageenan , Cyclooxygenase Inhibitors/pharmacology , DNA-Binding Proteins/metabolism , Disease Models, Animal , Drug Combinations , Exudates and Transudates/chemistry , Exudates and Transudates/cytology , HSP72 Heat-Shock Proteins , Heat Shock Transcription Factors , Humans , Indomethacin/pharmacology , Male , NF-kappa B p50 Subunit , Nitrobenzenes/pharmacology , Pleura/drug effects , Pleurisy/chemically induced , Prostaglandin D2/metabolism , Prostaglandins/chemistry , Rats , Rats, Wistar , Sulfonamides/pharmacology , Transcription Factor RelA , Transcription FactorsABSTRACT
In this study we have investigated the relationship between neointima formation and NF-kappaB activation in a model of endothelial denudation of rat carotid artery (balloon angioplasty) using the antioxidant pyrrolidine dithiocarbamate as inhibitor of NF-kappaB activation. Furthermore, we have correlated NF-kappaB activation to the expression of inducible isoforms of both nitric oxide synthase (iNOS) and cyclooxygenase (COX-2) in injured carotids. In control group a significant proliferation of neointima was observed 14 days after balloon angioplasty, which was correlated to an increase of NF-kappaB/DNA binding activity as well as p50/p65 nuclear levels compared to those observed in the carotids from naive or sham-operated rats. Furthermore, NF-kappaB activation was correlated to increased iNOS and COX-2, but not beta-actin, protein expression. Treatment of rats for 14 days with the antioxidant agent pyrrolidine dithiocarbamate (50, 100, 200 mg/kg per os and day) caused a significant inhibition of all the parameters assayed, except beta-actin protein expression. These results indicate that prevention of NF-kappaB activation may lead to the inhibition of neointima formation and suggest that antioxidant agents may have therapeutic relevance for the prevention of human restenosis.
Subject(s)
Blood Vessels/injuries , NF-kappa B/physiology , Angioplasty, Balloon , Animals , Antioxidants/pharmacology , Blood Vessels/drug effects , Blotting, Western , Carotid Arteries/drug effects , Carotid Arteries/physiology , Cyclooxygenase 2 , Densitometry , Electrophoretic Mobility Shift Assay , Endothelium, Vascular/drug effects , Isoenzymes/biosynthesis , Male , NF-kappa B/antagonists & inhibitors , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase Type II , Precipitin Tests , Proliferating Cell Nuclear Antigen/metabolism , Prostaglandin-Endoperoxide Synthases/biosynthesis , Pyrrolidines/pharmacology , Rats , Rats, Wistar , Thiocarbamates/pharmacologyABSTRACT
We investigated the occurrence and the role of HSF1 activation and inducible hsp72 expression in the carrageenin pleurisy in the rat. Molecular analysis performed on pleural cells collected from rat pleural cavity after carrageenin challenge revealed increased HSF1 activation and hsp72 expression. Moreover, local injection of a double-stranded oligodeoxynucleotide (ODN) containing the heat shock element sequence, acting as transcription factor decoy, exacerbated the inflammatory reaction. The exacerbation, induced by wild-type, but not by mutant ODN decoy, was associated to both inhibition of HSF1/DNA binding activity and reduction of hsp72 expression. In conclusion, this study shows that HSF1 activation and hsp72 expression both actually occur in acute inflammation and that the remission of the inflammatory reaction is tightly associated to the HSF1-dependent hsp72 expression, suggesting a a relevant role for the HSF1/hsp72 pathway as an endogenous anti-inflammatory system.
Subject(s)
DNA-Binding Proteins/metabolism , Heat-Shock Proteins/metabolism , Pleurisy/metabolism , Animals , Anti-Inflammatory Agents/metabolism , Carrageenan , DNA, Antisense/pharmacology , DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/genetics , Disease Models, Animal , Exudates and Transudates/metabolism , Gene Expression/drug effects , HSP72 Heat-Shock Proteins , Heat Shock Transcription Factors , Male , Pleurisy/chemically induced , Rats , Rats, Wistar , Time Factors , Transcription FactorsABSTRACT
SV-IV is a basic, thermostable, secretory protein of low Mr (9758) that is synthesized by rat seminal vesicle (SV) epithelium under strict androgen transcriptional control. This protein is of obvious pharmacological interest because it has potent nonspecies-specific immunomodulatory, anti-inflammatory, and pro-coagulant activities. In evaluating the clinical relevance and the possible use in medicine of SV-IV, we became interested in the study of its structure-function relationships and aimed to identify in its polypeptide chain specific peptide fragments possessing the marked anti-inflammatory properties of the protein not associated with other biological activities (pro-coagulation and immunomodulation) typical of this molecule. By using two different experimental approaches (the fragmentation of the protein into peptide derivatives by chemical methods and the organic synthesis on solid phase of selected peptide fragments), data were obtained showing that in this protein: (a) the immunomodulatory activity is related to the structural integrity of the whole molecule; (b) the anti-inflammatory activity is located in the N-terminal region of the molecule, the 8-16 peptide fragment being the most active; (c) the identified anti-inflammatory peptide derivatives do not seem to possess pro-coagulant activity, even though this particular function has been located in the 1-70 segment of the molecule.
Subject(s)
Anti-Inflammatory Agents/chemical synthesis , Peptide Fragments/chemical synthesis , Proteins/chemistry , Seminal Vesicle Secretory Proteins , Amino Acid Sequence , Animals , Anti-Inflammatory Agents/chemistry , Coagulants/chemical synthesis , Coagulants/chemistry , Cyanogen Bromide/chemistry , Immunosuppressive Agents/chemical synthesis , Immunosuppressive Agents/chemistry , Male , Molecular Sequence Data , Peptide Fragments/chemistry , Rats , Rats, WistarABSTRACT
OBJECTIVE AND DESIGN: The role of nitric oxide (NO) on leucocyte migration has been investigated in rat carrageenin-induced pleurisy. MATERIAL: Male Wistar rats. TREATMENT: L-arginine, NOC-18 and aminoguanidine were administered subcutaneously 1 h prior to carrageenin injection. METHODS: Leucocyte accumulation into the pleural cavity was measured 4 h after carrageenin challenge. Statistical significance was calculated by Bonferroni test. RESULTS: L-arginine (10 mg/kg) or the NO donor NOC-18 (10 mg/kg), significantly inhibited leucocyte infiltration by 31% and 20% respectively (P<0.01). On the contrary, when these compounds were given at high doses (L-arginine 300 mg/kg; NOC-18 30 mg/kg), leucocyte accumulation was increased by 22% and 33% respectively (P<0.01). Aminoguanidine, a relatively selective inhibitor of the inducible NO synthase, depending on the dose, showed a biphasic effect on cell migration. Thus, at low doses (30 and 100 mg/kg), aminoguanidine increased (by 40% and 74% respectively, P< 0.01) leucocyte infiltration which was inhibited by 41% (P < 0.01) when the drug was given at high dose (300 mg/kg). CONCLUSIONS: These results suggest that in rat carrageenin-induced pleurisy NO primarily inhibits leucocyte migration.
Subject(s)
Carrageenan , Cell Movement/drug effects , Leukocytes/physiology , Nitric Oxide/pharmacology , Pleurisy/pathology , Animals , Arginine/administration & dosage , Arginine/pharmacology , Blood Pressure , Enzyme Inhibitors/pharmacology , Guanidines/administration & dosage , Guanidines/pharmacology , Male , Nitric Oxide Donors/administration & dosage , Nitric Oxide Donors/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase Type II , Nitroso Compounds/administration & dosage , Nitroso Compounds/pharmacology , Pleura/pathology , Pleural Effusion/pathology , Pleural Effusion/physiopathology , Pleurisy/chemically induced , Rats , Rats, WistarABSTRACT
Most insulin-dependent diabetes mellitus patients gen-erate conformational autoantibodies to the islet-cell 65-kDa variant of human glutamate decarboxylase (GAD65), and several immunochemical tests for the early detection of type-1 diabetes rely on GAD65 antibody (GADA) assessment using properly folded recombinant GAD65 as the antigen. In addition, preventive therapies based on tolerization by GAD65 administration may be available in the near future. Therefore, there exists a strong interest in a facile and economically sound expression procedure for this antigen. Several attempts to produce, in native form, wild-type GAD65 in Escherichia coli have failed. However, this difficulty was recently surmounted in our laboratory by expressing GAD65 as a fusion protein with thioredoxin [Papouchado, Valdez, Ghiringhelli, Poskus and Ermácora (1997) Eur. J. Biochem. 246, 350-359]. In this work, a new GAD65 hybrid gene was prepared by joining engineered cDNA obtained from human and rat tissues. The new gene was modified additionally to finally code for human GAD65 with a single amino-acid substitution: Met-161-->Thr. This change impeded the co-expression of a 48-kDa by-product from an internal translation site. Also, a second 58-kDa by-product was identified as a GAD65 C-terminal proteolytic fragment that co-purifies with thioredoxin-M161T GAD65. The new GAD65 variant was expressed and easily purified, yielding an antigen that performed equally or better than wild-type GAD65 in the reference radiobinding assay for GADA. The procedure provides an inexpensive source of large amounts of fully active and immunochemically competent GAD65.
Subject(s)
Escherichia coli/genetics , Glutamate Decarboxylase/genetics , Glutamate Decarboxylase/metabolism , Amino Acid Sequence , Amino Acid Substitution , Animals , Base Sequence , Cloning, Molecular , Humans , Methionine , Molecular Sequence Data , Protein Engineering/methods , Rats , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Thioredoxins/genetics , Thioredoxins/metabolism , ThreonineABSTRACT
The effect of four macrolide antibiotics (roxithromycin, clarithromycin, erythromycin, and azithromycin) on the generation of some mediators and cytokines involved in the inflammatory process has been studied both in vivo and in vitro. Rat carrageenin pleurisy was used as a model of acute inflammation, and the macrolides were administered (10, 20, and 40 mg/kg p.o.) 1 h before the carrageenin challenge. Exudate volume and leukocyte accumulation were both dose-dependently reduced by roxithromycin, clarithromycin and erythromycin in either normal or adrenalectomized animals. Furthermore, in normal rats, prostaglandin (PG)E(2), nitrate plus nitrite, and tumor necrosis factor-alpha levels in pleural exudate were significantly reduced by these macrolides. Roxithromycin appeared more effective than erythromycin and clarithromycin, whereas azithromycin only slightly affected the inflammatory reaction. None of the macrolides were able to modify leukotriene B(4) exudate levels. In vitro experiments have shown that the four macrolides (5-80 microM) reduced in a concentration-dependent manner the production of 6-keto-PGF(1alpha), NO(2)(-), tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 by lipopolysaccharide-stimulated J774 macrophages. In J774 cells, the inhibition of 6-keto-PGF(1alpha) and NO(2)(-) production by roxithromycin and erythromycin was not dependent on direct inhibition of cyclooxygenase-2 and inducible nitric oxide synthase activity because it appears to be related to the inhibition of cyclooxygenase-2 and inducible nitric oxide synthase protein expression. In conclusion, the present study shows that macrolide antibiotics have anti-inflammatory activity, which likely depends on their ability to prevent the production of proinflammatory mediators and cytokines, and suggest that these agents, particularly roxithromycin, can exert therapeutic effects independently of their antibacterial activity.
Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Inflammatory Agents/pharmacology , 6-Ketoprostaglandin F1 alpha/biosynthesis , Adrenalectomy , Anesthesia , Animals , Azithromycin/pharmacology , Carrageenan , Cell Line , Clarithromycin/pharmacology , Cyclooxygenase 2 , Cytokines/biosynthesis , Dinoprostone/metabolism , Dose-Response Relationship, Drug , Erythromycin/pharmacology , Inflammation Mediators/metabolism , Isoenzymes/metabolism , Leukotriene B4/metabolism , Macrophages/metabolism , Mice , Nitrates/metabolism , Nitric Oxide/biosynthesis , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Nitrites/metabolism , Pleurisy/chemically induced , Pleurisy/prevention & control , Prostaglandin-Endoperoxide Synthases/metabolism , Rats , Roxithromycin/pharmacology , Time Factors , Tumor Necrosis Factor-alpha/metabolismABSTRACT
To obtain information about the structure-activity relationships of analgesic peptides, we modified the previously reported tripeptide, H-Lys-Pro-Thr-OH (C). The proline part in C was replaced with various analogues of unconventional amino acids [(3aS, 7aS)-octahydroindole-2-carboxylic acid (Oic), (S,S,S,)-2-azabiciclo [3.3.0]octane-3-carboxylic acid (Aoc), D-Aoc, and (2S, 4R)-hydroxyproline (Hyp)] with varying lipophilic, steric, and conformational properties, and alternatively with Lys and Orn in the lysine part. Moreover, the threonine part was changed to various natural amino acids (Ser, Thr, Val, Leu). All the compound were screened in vivo for their analgesic effects in mouse writhing test. Compound 24 (H-Orn-Hyp-Val-OH), the most active compound within the series, showed an ED50 value of 10 mg/kg, which is comparable with the ED50 values exhibited by indometacin (4.1 mg/kg) and the dipeptide H-Lys-D-Pro-OH (6.9 mg/kg), both used as reference drugs.